Press Releases

Date	Title
June 29, 2021	Angion Announces Results from the Phase 2 ALI-201 Study in Patients with COVID-19 Associated Pneumonia	PDF Version
May 17, 2021	Angion Provides Corporate Update and Reports First Quarter 2021 Financial Results	PDF Version
April 29, 2021	Angion and Vifor Pharma Announce Completion of Enrollment in Phase 2 Study of ANG-3777 for Cardiac-Surgery Associated Acute Kidney Injury	PDF Version
March 30, 2021	Angion Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results	PDF Version
March 25, 2021	Angion Completes Enrollment in Phase 2 Study of ANG-3777 for Acute Lung Injury in Patients with COVID-19 Associated Pneumonia	PDF Version
March 19, 2021	Angion Announces Partial Waiver of Certain Lock-up Restrictions	PDF Version
February 24, 2021	Angion to Participate in Upcoming March Investment Conferences	PDF Version
February 9, 2021	Angion Biomedica Corp. Announces Closing of $117 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	PDF Version
February 5, 2021	Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement	PDF Version